Tci Gene (ROCO:6879) Revenue per Share : NT$12.61 (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Tci Gene Revenue per Share?

Tci Gene's revenue per share for the six months ended in Dec. 2023 was NT$6.95. Tci Gene's revenue per share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$12.61.

Warning Sign:

Tci Gene Inc revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue Per Share Growth Rate of Tci Gene was -26.90% per year. During the past 3 years, the average Revenue Per Share Growth Rate was 6.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for Tci Gene's Revenue per Share or its related term are showing as below:

ROCO:6879' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 6.9 Med: 13.4 Max: 19.9
Current: 6.9

During the past 5 years, Tci Gene's highest 3-Year average Revenue Per Share Growth Rate was 19.90% per year. The lowest was 6.90% per year. And the median was 13.40% per year.

ROCO:6879's 3-Year Revenue Growth Rate is ranked better than
55% of 780 companies
in the Biotechnology industry
Industry Median: 3.6 vs ROCO:6879: 6.90

Tci Gene Revenue per Share Historical Data

The historical data trend for Tci Gene's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tci Gene Revenue per Share Chart

Tci Gene Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Revenue per Share

10.00

10.31

21.84

17.25

12.61

Tci Gene Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Revenue per Share	Get a 7-Day Free Trial				14.26	11.12	6.54	5.66	6.95

Competitive Comparison of Tci Gene's Revenue per Share

For the Biotechnology subindustry, Tci Gene's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tci Gene's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tci Gene's PS Ratio distribution charts can be found below:

* The bar in red indicates where Tci Gene's PS Ratio falls into.

Tci Gene Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Tci Gene's Revenue Per Share for the fiscal year that ended in Dec. 2023 is calculated as

Revenue Per Share (A: Dec. 2023 )	=	Revenue (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	333.855	/	26.482
	=	12.61

Tci Gene's Revenue Per Share for the quarter that ended in Dec. 2023 is calculated as

Revenue Per Share (Q: Dec. 2023 )	=	Revenue (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	183.992	/	26.468
	=	6.95

Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$12.61

Tci Gene (ROCO:6879) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Tci Gene Revenue per Share Related Terms

Thank you for viewing the detailed overview of Tci Gene's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Tci Gene (ROCO:6879) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tci Gene Inc (ROCO:6879) » Definitions » Revenue per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 185-1, Gangqian Rd, 10th FLoor, Neihu District, Taipei, TWN

Website

https://www.genext.me

Tci Gene Inc provides precision preventive medicines in Taiwan. It is the first to introduce the concept of precision preventive medicine with Predict prediction, Prevent prevention, and Personal Treatment personalized health management measures.

Tci Gene (ROCO:6879) Headlines

No Headlines